{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T12:15:53Z","timestamp":1769688953511,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,8,28]],"date-time":"2015-08-28T00:00:00Z","timestamp":1440720000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s13277-015-3959-0","type":"journal-article","created":{"date-parts":[[2015,8,27]],"date-time":"2015-08-27T09:06:35Z","timestamp":1440666395000},"page":"1727-1738","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Aspirin and salicylic acid decrease c-Myc expression in cancer cells: a potential role in chemoprevention"],"prefix":"10.1007","volume":"37","author":[{"given":"Guoqiang","family":"Ai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh","family":"Dachineni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pratik","family":"Muley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hemachand","family":"Tummala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Jayarama","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,8,28]]},"reference":[{"key":"3959_CR1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrclinonc.2011.199","volume":"9","author":"MJ Thun","year":"2012","unstructured":"Thun MJ, Jacobs EJ, Patrono C. The role of aspirin in cancer prevention. Nature Rev Clin Oncol. 2012;9:259\u201367.","journal-title":"Nature Rev Clin Oncol"},{"key":"3959_CR2","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S0140-6736(11)61720-0","volume":"379","author":"PM Rothwell","year":"2012","unstructured":"Rothwell PM, Price JF, Fowkes FGR, Zanchetti A, Roncaglioni MC, Tognoni G, et al. Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials. Lancet. 2012;379:1602\u201312.","journal-title":"Lancet"},{"key":"3959_CR3","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1093\/jnci\/djs452","volume":"104","author":"VV Sahasrabuddhe","year":"2012","unstructured":"Sahasrabuddhe VV, Gunja MZ, Graubard BI, Trabert B, Schwartz LM, Park Y, et al. Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma. J Natl Cancer Inst. 2012;104:1808\u201314.","journal-title":"J Natl Cancer Inst"},{"key":"3959_CR4","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1002\/cncr.27817","volume":"119","author":"CA Gamba","year":"2013","unstructured":"Gamba CA, Swetter SM, Stefanick ML, Kubo J, Desai M, Spaunhurst KM, et al. Aspirin is associated with lower melanoma risk among postmenopausal Caucasian women: The Women's Health Initiative. Cancer. 2013;119:1562\u20139.","journal-title":"Cancer"},{"key":"3959_CR5","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.ejca.2012.09.030","volume":"49","author":"T Veitonmaki","year":"2013","unstructured":"Veitonmaki T, Tammela TL, Auvinen A, Murtola TJ. Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level. Eur J Cancer. 2013;49:938\u201345.","journal-title":"Eur J Cancer"},{"key":"3959_CR6","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1093\/carcin\/bgm101","volume":"28","author":"MG Luciani","year":"2007","unstructured":"Luciani MG, Campregher C, Gasche C. Aspirin blocks proliferation in colon cells by inducing a G1 arrest and apoptosis through activation of the checkpoint kinase ATM. Carcinogenesis. 2007;28:2207\u201317.","journal-title":"Carcinogenesis"},{"key":"3959_CR7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0006-2952(97)00400-0","volume":"55","author":"L Qiao","year":"1998","unstructured":"Qiao L, Hanif R, Sphicas E, Shiff SJ, Rigas B. Effect of aspirin on induction of apoptosis in ht-29 human colon adenocarcinoma cells. Biochem Pharmacol. 1998;55:53\u201364.","journal-title":"Biochem Pharmacol"},{"key":"3959_CR8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/excr.1996.0023","volume":"222","author":"SJ Shiff","year":"1996","unstructured":"Shiff SJ, Koutsos MI, Qiao L, Rigas B. Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis. Exp Cell Res. 1996;222:179\u201388.","journal-title":"Exp Cell Res"},{"key":"3959_CR9","first-page":"383","volume":"9","author":"A Goel","year":"2003","unstructured":"Goel A, Chang DK, Ricciardiello L, Gasche C, Boland CR. A novel mechanism for aspirin-mediated growth inhibition of human colon cancer cells. Clin Cancer Res. 2003;9:383\u201390.","journal-title":"Clin Cancer Res"},{"key":"3959_CR10","doi-asserted-by":"crossref","first-page":"e48208","DOI":"10.1371\/journal.pone.0048208","volume":"7","author":"S Pathi","year":"2012","unstructured":"Pathi S, Jutooru I, Chadalapaka G, Nair V, Lee SO, Safe S. Aspirin inhibits colon cancer cell and tumor growth and downregulates specificity protein (sp) transcription factors. PLoS One. 2012;7:e48208.","journal-title":"PLoS One"},{"key":"3959_CR11","first-page":"511","volume":"23","author":"S Bousserouel","year":"2010","unstructured":"Bousserouel S, Gosse F, Bouhadjar M, Soler L, Marescaux J, Raul F. Long-term administration of aspirin inhibits tumour formation and triggers anti-neoplastic molecular changes in a pre-clinical model of colon carcinogenesis. Oncol Rep. 2010;23:511\u20137.","journal-title":"Oncol Rep"},{"key":"3959_CR12","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1136\/gut.52.11.1598","volume":"52","author":"B Shpitz","year":"2003","unstructured":"Shpitz B, Klein E, Buklan G, Neufeld D, Nissan A, Freund HR, et al. Suppressive effect of aspirin on aberrant crypt foci in patients with colorectal cancer. Gut. 2003;52:1598\u2013601.","journal-title":"Gut"},{"key":"3959_CR13","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/jama.2009.1112","volume":"302","author":"AT Chan","year":"2009","unstructured":"Chan AT, Ogino S, Fuchs CS. Aspirin use and survival after diagnosis of colorectal cancer. JAMA: J Am Med Assoc. 2009;302:649\u201358.","journal-title":"JAMA: J Am Med Assoc"},{"key":"3959_CR14","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.8052854","volume":"265","author":"E Kopp","year":"1994","unstructured":"Kopp E, Ghosh S. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science. 1994;265:956\u20139.","journal-title":"Science"},{"key":"3959_CR15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0049-3848(03)00379-7","volume":"110","author":"JR Vane","year":"2003","unstructured":"Vane JR, Botting RM. The mechanism of action of aspirin. Thromb Res. 2003;110:255\u20138.","journal-title":"Thromb Res"},{"key":"3959_CR16","doi-asserted-by":"crossref","unstructured":"Dovizio M, Bruno A, Tacconelli S, Patrignani P: Mode of action of aspirin as a chemopreventive agent. Recent results in cancer research Fortschritte der Krebsforschung Progres dans les recherches sur le cancer 2013;191:39\u201365","DOI":"10.1007\/978-3-642-30331-9_3"},{"key":"3959_CR17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/bjc.2014.271","volume":"111","author":"L Alfonso","year":"2014","unstructured":"Alfonso L, Ai G, Spitale RC, Bhat GJ. Molecular targets of aspirin and cancer prevention. Br J Cancer. 2014;111:61\u20137.","journal-title":"Br J Cancer"},{"key":"3959_CR18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF00543800","volume":"25","author":"MS Roberts","year":"1983","unstructured":"Roberts MS, Rumble RH, Wanwimolruk S, Thomas D, Brooks PM. Pharmacokinetics of aspirin and salicylate in elderly subjects and in patients with alcoholic liver disease. Eur J Clin Pharmacol. 1983;25:253\u201361.","journal-title":"Eur J Clin Pharmacol"},{"key":"3959_CR19","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1096\/fj.06-5987com","volume":"20","author":"GM Borthwick","year":"2006","unstructured":"Borthwick GM, Johnson AS, Partington M, Burn J, Wilson R, Arthur HM. Therapeutic levels of aspirin and salicylate directly inhibit a model of angiogenesis through a cox-independent mechanism. FASEB J. 2006;20:2009\u201316.","journal-title":"FASEB J"},{"key":"3959_CR20","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.semcancer.2006.07.014","volume":"16","author":"CV Dang","year":"2006","unstructured":"Dang CV, O'Donnell KA, Zeller KI, Nguyen T, Osthus RC, Li F. The c-Myc target gene network. Semin Cancer Biol. 2006;16:253\u201364.","journal-title":"Semin Cancer Biol"},{"key":"3959_CR21","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.semcancer.2006.07.015","volume":"16","author":"M Vita","year":"2006","unstructured":"Vita M, Henriksson M. The Myc oncoprotein as a therapeutic target for human cancer. Semin Cancer Biol. 2006;16:318\u201330.","journal-title":"Semin Cancer Biol"},{"key":"3959_CR22","doi-asserted-by":"crossref","first-page":"8843","DOI":"10.1073\/pnas.0403046101","volume":"101","author":"B Amati","year":"2004","unstructured":"Amati B. Myc degradation: dancing with ubiquitin ligases. Proc Natl Acad Sci U S A. 2004;101:8843\u20134.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3959_CR23","doi-asserted-by":"crossref","first-page":"a014266","DOI":"10.1101\/cshperspect.a014266","volume":"4","author":"MR McKeown","year":"2014","unstructured":"McKeown MR, Bradner JE. Therapeutic strategies to inhibit MYC. Cold Spring Harbor Perspect Med. 2014;4:a014266.","journal-title":"Cold Spring Harbor Perspect Med"},{"key":"3959_CR24","doi-asserted-by":"crossref","unstructured":"Chio II, Yordanov G, Tuveson D. MAX-ing out MYC: a novel small molecule inhibitor against MYC-dependent tumors. J Natl Cancer Inst. 2014;106.","DOI":"10.1093\/jnci\/dju365"},{"key":"3959_CR25","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.cell.2010.03.030","volume":"141","author":"PB Rahl","year":"2010","unstructured":"Rahl PB, Lin CY, Seila AC, Flynn RA, McCuine S, Burge CB, et al. c-Myc regulates transcriptional pause release. Cell. 2010;141:432\u201345.","journal-title":"Cell"},{"key":"3959_CR26","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW. NIH image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9:671\u20135.","journal-title":"Nat Methods"},{"key":"3959_CR27","first-page":"597","volume":"34","author":"LF Alfonso","year":"2009","unstructured":"Alfonso LF, Srivenugopal KS, Arumugam TV, Abbruscato TJ, Weidanz JA, Bhat GJ. Aspirin inhibits camptothecin-induced p21CIP1 levels and potentiates apoptosis in human breast cancer cells. Int J Oncol. 2009;34:597\u2013608.","journal-title":"Int J Oncol"},{"key":"3959_CR28","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/bmc.973","volume":"22","author":"SK Bae","year":"2008","unstructured":"Bae SK, Seo KA, Jung EJ, Kim HS, Yeo CW, Shon JH, et al. Determination of acetylsalicylic acid and its major metabolite, salicylic acid, in human plasma using liquid chromatography-tandem mass spectrometry: application to pharmacokinetic study of Astrix in Korean healthy volunteers. Biomed Chromatogr: BMC. 2008;22:590\u20135.","journal-title":"Biomed Chromatogr: BMC"},{"key":"3959_CR29","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.cell.2010.06.037","volume":"142","author":"M Conacci-Sorrell","year":"2010","unstructured":"Conacci-Sorrell M, Ngouenet C, Eisenman RN. Myc-nick: a cytoplasmic cleavage product of Myc that promotes alpha-tubulin acetylation and cell differentiation. Cell. 2010;142:480\u201393.","journal-title":"Cell"},{"key":"3959_CR30","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/j.gastro.2012.02.050","volume":"142","author":"FV Din","year":"2012","unstructured":"Din FV, Valanciute A, Houde VP, Zibrova D, Green KA, Sakamoto K, et al. Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells. Gastroenterology. 2012;142:1504\u201315. e1503.","journal-title":"Gastroenterology"},{"key":"3959_CR31","doi-asserted-by":"crossref","first-page":"38261","DOI":"10.1074\/jbc.M005545200","volume":"275","author":"BK Law","year":"2000","unstructured":"Law BK, Waltner-Law ME, Entingh AJ, Chytil A, Aakre ME, Norgaard P, et al. Salicylate-induced growth arrest is associated with inhibition of p70s6k and down-regulation of c-myc, cyclin D1, cyclin a, and proliferating cell nuclear antigen. J Biol Chem. 2000;275:38261\u20137.","journal-title":"J Biol Chem"},{"key":"3959_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/757534","volume":"2014","author":"WP Tansey","year":"2014","unstructured":"Tansey WP. Mammalian MYC proteins and cancer. New J Sci. 2014;2014:1\u201327.","journal-title":"New J Sci"},{"key":"3959_CR33","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1128\/MCB.20.7.2423-2435.2000","volume":"20","author":"MA Gregory","year":"2000","unstructured":"Gregory MA, Hann SR. c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells. Mol Cell Biol. 2000;20:2423\u201335.","journal-title":"Mol Cell Biol"},{"key":"3959_CR34","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1128\/MCB.8.8.3373","volume":"8","author":"G Krystal","year":"1988","unstructured":"Krystal G, Birrer M, Way J, Nau M, Sausville E, Thompson C, et al. Multiple mechanisms for transcriptional regulation of the myc gene family in small-cell lung cancer. Mol Cell Biol. 1988;8:3373\u201381.","journal-title":"Mol Cell Biol"},{"key":"3959_CR35","first-page":"1273","volume":"39","author":"S Marimuthu","year":"2011","unstructured":"Marimuthu S, Chivukula RS, Alfonso LF, Moridani M, Hagen FK, Bhat GJ. Aspirin acetylates multiple cellular proteins in HCT-116 colon cancer cells: identification of novel targets. Int J Oncol. 2011;39:1273\u201383.","journal-title":"Int J Oncol"},{"key":"3959_CR36","doi-asserted-by":"crossref","first-page":"a014365","DOI":"10.1101\/cshperspect.a014365","volume":"4","author":"AS Farrell","year":"2014","unstructured":"Farrell AS, Sears RC. Myc degradation. Cold Spring Harbor Perspect Med. 2014;4:a014365.","journal-title":"Cold Spring Harbor Perspect Med"},{"key":"3959_CR37","first-page":"6566","volume":"49","author":"M-E Forgue-Lafitte","year":"1989","unstructured":"Forgue-Lafitte M-E, Coudray A-M, Br\u00e9ant B, Me\u0161ter J. Proliferation of the human colon carcinoma cell line HT29: autocrine growth and deregulated expression of the c-myc oncogene. Cancer Res. 1989;49:6566\u201371.","journal-title":"Cancer Res"},{"key":"3959_CR38","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1177\/1947601910378691","volume":"1","author":"J Xu","year":"2010","unstructured":"Xu J, Chen Y, Olopade OI. Myc and breast cancer. Genes Cancer. 2010;1:629\u201340.","journal-title":"Genes Cancer"},{"key":"3959_CR39","doi-asserted-by":"crossref","first-page":"9545","DOI":"10.1073\/pnas.1121119109","volume":"109","author":"M Toyoshima","year":"2012","unstructured":"Toyoshima M, Howie HL, Imakura M, Walsh RM, Annis JE, Chang AN, et al. Functional genomics identifies therapeutic targets for MYC-driven cancer. Proc Natl Acad Sci U S A. 2012;109:9545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3959_CR40","first-page":"525","volume":"2015","author":"S Fletcher","year":"1849","unstructured":"Fletcher S, Prochownik EV. Small-molecule inhibitors of the Myc oncoprotein. Biochim Biophys Acta. 1849;2015:525\u201343.","journal-title":"Biochim Biophys Acta"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-3959-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-015-3959-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-3959-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T15:29:32Z","timestamp":1559489372000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-015-3959-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,28]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["3959"],"URL":"https:\/\/doi.org\/10.1007\/s13277-015-3959-0","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,28]]}}}